NewAmsterdam Pharma Hits Day High with 9% Surge in Stock Price

NewAmsterdam Pharma Co. NV has experienced a significant uptick in its stock performance, gaining 9.0% on July 21, 2026. The stock reached an intraday high of USD 32.44, showcasing notable activity within the pharmaceuticals and biotechnology sector. Despite this day's positive movement, the company's performance over the past week has seen a decline of 2.85%, contrasting with a slight decrease of 0.46% in the S&P 500. Over the past month, NewAmsterdam Pharma has shown a robust increase of 8.41%, significantly outperforming the S&P 500's modest gain of 0.11%. On a yearly basis, the stock has delivered an impressive return of 43.35%, compared to the S&P 500's 19.09%. However, year-to-date performance indicates a decline of 7.81%, while the S&P 500 has gained 9.7%. Over the longer term, NewAmsterdam Pharma has demonstrated remarkable growth, with a 175.23% increase over three years and a staggering 232.72% over five years. Despite these positive indicators, the company has faced challenges, including negative results in recent quarters and a significant decline in net sales. Promoter confidence appears to be waning, with a decrease in their stake in the company.